NCT01698814View on ClinicalTrials.gov

A Six-Week Safety Study of an Investigational Ophthalmic Solution

PHASE3CompletedINTERVENTIONAL

Enrollment

518

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Allergic Conjunctivitis

Interventions

DRUG

AL-4943A Ophthalmic Solution

DRUG

AL-4943A Ophthalmic Solution Vehicle

Inactive ingredients used as placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY